Sponsored By
Smith & Nephew (SN.) Short Positions
Add to Alert listActive Short Positions
| Holder | Position | Change | Date | |
|---|---|---|---|---|
| Point72 Asset Management, L.P. | 0.61% | 0 | 08-Jul-2026 | View History |
| Millennium International Management LP | 1.71% | 0 | 07-Jul-2026 | View History |
| Citadel Advisors LLC | 1.58% | 0 | 06-Jul-2026 | View History |
| Ilex Capital Partners (UK) LLP | 0.52% | 0 | 06-Jul-2026 | View History |
| Two Sigma Investments, LP | 0.6% | 0 | 06-Jul-2026 | View History |
| Holocene Advisors LP | 1.31% | 0 | 23-Jun-2026 | View History |
| AKO Capital LLP | 0.7% | 0 | 16-Jun-2026 | View History |
| Two Sigma Investments, LP | 0.6% | 0 | 06-Mar-2026 | View History |
| Citadel Advisors LLC | 1.1% | 0 | 23-Feb-2026 | View History |
| Millennium International Management LP | 0.78% | 0 | 04-Feb-2026 | View History |
| Millennium International Management LP | 0.57% | 0 | 08-Dec-2025 | View History |
Historical Short Positions
Smith & Nephew is a British medical technology company that develops, manufactures, and sells medical devices. Products include arthroscopy, trauma, clinical therapy, and orthopaedic reconstruction products. Smith & Nephew's products are sold in over 100 countries, including Europe, the Americas, Asia Pacific, the Middle East, and Africa.
Smith & Nephew operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management.
Smith & Nephew's shares are traded in London and New York, and the company is a constituent of the UK's FTSE100.
Smith and Nephew share price launched at 182p in 1988.
Note: This description is in part generated by AI and not an endorsement by or the opinion of Investegate
Latest directors dealings
- 4 hours ago Schroder Income Growth Fund
- 5 hours ago Oberon AIM VCT
- 6 hours ago Johnson Matthey
- 6 hours ago Sirius Real Estate Ltd.
- 6 hours ago GSK